Sfoglia per AUTORE
BERARDI R
Collezione AO Cuneo

  

Items : 11

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Aug;75(4):460-470. doi: 10.23736/S2724-6051.23.05369-7.

2023
AO Cuneo
ASL Cuneo 2
AOU Novara

Grande E; Santoni M; Buti S; Battelli N; Sorgentoni G; Pierantoni F; Monteiro FS; Rebuzzi SE; Roviello G; Soares A; Zabalza IO; Rizzo A; Bisonni R; Morelli F; Incorvaia L; Küronya Z; Mosca A; Bhuva D; Santini D; Vau N; Messina C; Merler S; Landmesser J; Grillone F; Ortega C; Sunela K; Ansari J; Atzori F; Bassanelli M; et alii...

Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study. in Clinical breast cancer / Clin Breast Cancer. 2021 Oct;21(5):e489-e496. doi: 10.1016/j.clbc.2020.11.001. Epub 2020 Nov 9.

2021
AO Cuneo

Porcu L; Barni S; Farina G; Berardi R; Moretti A; Frassoldati A; Foglietta J; Zaniboni A; Rimanti A; Bareggi C; Brunello A; Palumbo R; Garrone O; Bonotto M; Pinotti G; Blasi L; Collovà E; La Verde N;

TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study. in Cancers / Cancers (Basel). 2021 Jun 7;13(11):2839. doi: 10.3390/cancers13112839.

2021
AO Ordine Mauriziano
AO Cuneo

Zaniboni A; Tamburini E; Tamberi S; Strippoli A; Spallanzani A; Smiroldo V; Silvestris N; Ratti M; Pucci F; Ongaro E; Murialdo R; Lonardi S; Iachetta F; Granetto C; Fornaro L; Frassineti GL; Di Maio M; De Vita F; De Manzoni G; Cardellino GG; Berardi R; Aprile G; Antonuzzo L; Aglietta M; Prisciandaro M; Di Bartolomeo M; Palermo F; Raimondi A; Cremolini C; et alii...

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial. in Scientific reports / Sci Rep. 2021 Jul 2;11(1):13770. doi: 10.1038/s41598-021-92774-z.

2021
AO Cuneo

Vici P; Ciliberto G; Sanguineti G; Di Leo A; De Maria R; Daralioti T; Sperduti I; Perracchio L; di Benedetto A; Del Medico P; Roselli M; Vaccaro A; Garufi C; Cazzaniga M; Lorusso V; Russo A; Pistelli M; Giotta F; Meattini I; Garrone O; Paris I; Sarobba G; Veltri E; Corsi D; D'Ostilio N; Grassadonia A; Valerio MR; Mirabelli R; Fabbri MA; et alii...

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study. in Breast cancer research and treatment / Breast Cancer Res Treat. 2021 Dec;190(3):415-424. doi: 10.1007/s10549-021-06375-5. Epub 2021 Sep 21.

2021
ASL Asti
AO Cuneo
AOU Città della Salute di Torino

Vallini I; Clivio L; Di Mauro P; Cogliati V; Capici S; Toniolo D; Tralongo P; Turletti A; Valenza R; Valerio MR; Vici P; Spadaro P; Taverniti C; Scognamiglio G; Sarobba MG; Schintu MG; Saracchini S; Santini D; Riccardi F; Putzu C; Nicolini M; Musolino A; Sarti S; Marchetti P; Grassadonia A; Leonardi V; Giovanardi F; Gianni L; Generali D; et alii...

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence. in Journal of cellular physiology / J Cell Physiol. 2020 Nov;235(11):7900-7910. doi: 10.1002/jcp.29445. Epub 2020 Jan 15.

2020
AO Cuneo

Vici P; Giordano A; Barba M; Mazzotta M; Sperduti I; Ciliberto G; Villa A; Risi E; De Maria R; Del Medico P; Generali D; Meattini I; Livi L; Garrone O; Baldini E; Zamagni C; Pistelli M; Cannita K; Valerio MR; Berardi R; Russo A; Ricciardi G; Adamo V; Ficorella C; Roselli M; Lorusso V; Landucci E; Paris I; Giotta F; et alii...

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2020 Dec 10;39(1):279. doi: 10.1186/s13046-020-01797-3.

2020
AO Cuneo

Roselli M; Del Medico P; Cazzaniga M; Garufi C; Sarobba G; Giotta F; Paris I; Garrone O; Veltri E; Corsi D; D'Ostilio N; Fabbri MA; Russo A; Mirabelli R; Valerio MR; Marchetti P; Tomao S; Marinelli D; Mazzotta M; Barchiesi G; Zamagni C; Tonini G; Adamo V; Michelotti A; Moscetti L; Bria E; Cassano A; La Verde N; Generali D; et alii...

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting. in International journal of cancer / Int J Cancer. 2020 Apr 1;146(7):1917-1929. doi: 10.1002/ijc.32583. Epub 2019 Aug 7.

2020
AO Cuneo

Vici P; Di Leo A; Barba M; Villa A; Ciliberto G; Sperduti I; De Maria R; Risi E; Generali D; De Tursi M; Sarobba G; Del Medico P; Meattini I; Desideri I; Livi L; Baldini E; Di Cocco B; Foglietta J; Greco F; Zamagni C; Garrone O; D'Ostilio N; Sini V; Cannita K; Adamo V; Ricciardi GRR; Fiorio E; Pistelli M; Russo A; et alii...

An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival. in Frontiers in oncology / Front Oncol. 2020 Sep 15;10:1652. doi: 10.3389/fonc.2020.01652. eCollection 2020.

2020
ASL Città di Torino
AO Cuneo

Randon G; Berardi R; Ferrucci PF; Strippoli S; Vitale MG; Ascierto PA; Pigozzo J; Palmieri G; Quadrini S; Cortellini A; Occelli M; Nigro O; Rossi E; Tronconi MC; Marconcini R; Ferraresi V; Quaglino P; Indini A; Guida M; Stucci LS; Di Guardo L; Morgese F; Pala L; Minisini AM; Palla M; Sileni VC; Todisco A; Mandala M; Mannavola F; et alii...

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study. in Breast (Edinburgh, Scotland) / Breast. 2019 Dec;48:7-16. doi: 10.1016/j.breast.2019.07.006. Epub 2019 Aug 22.

2019
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Città di Torino
ASL Vercelli

Clivio L; Cavanna L; Ciccarese M; Vici P; Valerio MR; Valenza R; Turletti A; Tralongo P; Toniolo D; Taverniti C; Spadaro P; Scognamiglio G; Schintu MG; Sarobba MG; Saracchini S; Santini D; Riccardi F; Nicolini M; Putzu C; Musolino A; Melegari E; Marchetti P; Leonardi V; Grassadonia A; Giovanardi F; Generali D; Gianni L; Gebbia V; Gambaro AR; et alii...

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. in Gastroenterology / Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo

Mazzaferro V; Delle Fave G; Buzzoni R; Giacomelli L; Milione M; Lo Russo G; Prinzi N; Concas L; Femia D; Tafuto S; Garattini SK; Di Costanzo F; Torniai M; Bajetta E; Ortolani S; Zaniboni A; Puliafito I; Panzuto F; Brighi N; Colao A; La Salvia A; Bongiovanni A; Ricci S; Fazio N; Cavalcoli F; Cauchi C; Duro M; Carnaghi C; Davì MV; et alii...